FDA Sends Warning Letters to Multiple Companies for Illegally Marketing CBD Products
NORML
NOVEMBER 25, 2019
Representatives of the US Food and Drug Administration issued warning letters on Monday to multiple companies for marketing CBD-specific products in ways that violate federal law. The agency issued warning letters to 15 commercial entities. Seven additional companies received similar letters earlier this year.
Let's personalize your content